The growing prevalence of allergic conditions such as allergic rhinitis, asthma, atopic dermatitis is fueling demand for effective treatments. According to WHO, around 300 million people worldwide suffer from asthma. Additionally, allergic rhinitis affects approximately 500 million people globally. Mometasone furoate has proven to be an effective inhaled corticosteroid used for the treatment of these conditions. The rising disease burden and availability of novel delivery forms are expected to propel the market forward.

Companies in the Mometasone Furoate Market Size are actively expanding their global footprint, especially in developing regions of Latin America, Asia Pacific and Middle East & Africa. These regions present lucrative opportunities for growth due to rising medical needs of the growing population and improving access to healthcare. Key players have made several strategic acquisitions and collaborations to augment their production capabilities and commercialization networks in high potential markets. This will further facilitate global market expansion over the coming years.

Get more insights on Mometasone Furoate Market

Also Read Related Article on Disposable Surgical Sheets